article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

Three Ways AI, If Trusted, Can Transform the Healthcare Landscape

Healthcare IT Today

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Nvidia spends $1 Billion acquiring Two Israeli AI startups with massive HealthTech and Healthcare AI potential

Lloyd Price

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Email lloyd@nelsonadvisors.co.uk Visit [link]

article thumbnail

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

We are excited to support Seamless Therapeutics in its pursuit of taking a leadership position in the rapidly evolving gene editing arena,” added Karl Nägler, PhD, Managing Partner at Wellington Partners. “At Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space. Forbion manages well over EUR 2.3